Omnicell
Eileen Voynick
Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming the pharmacy care delivery model, announced this week that the Board of Directors had elected Eileen Voynick to the board.
The appointment was effective Jan. 5.
Voynick fills the vacancy resulting from the decision of Sara J. White, a Class I director, to step down.
The company also announced that Vance Moore will not stand for reelection to the company’s board at Omnicell’s 2024 annual meeting of stockholders.
The size of the board will be reduced from 10 to nine directors, according to a press release.
Voynick has been appointed to the board’s Corporate Governance Committee.
“Eileen is a widely respected leader with significant experience in the software, technology, and healthcare industries, as well as a proven track record creating value for stockholders, accelerating growth, driving operational excellence, and developing global businesses,” said Randall Lipps, chairman, president, CEO, and founder of Omnicell. “I am confident that her skills will complement and strengthen our board as Omnicell continues to focus on driving long-term value and delivering outcome-centric innovations to improve patient outcomes.”
Voynick brings more than three decades of experience driving sales and operations at global industry leaders, including in the healthcare technology industry, at the executive and board level.
Most recently she served as CEO of Sparta Systems Inc., a leading provider of enterprise-quality management software solutions.
Prior to Sparta Systems, Voynick served as COO at Allscripts Healthcare Solutions, Inc. (now known as Veradigm Inc.); as executive vice president of global sales, services, and support at Misys Healthcare Systems; and in various management positions at Oracle, SAP, Siebel Systems, Gartner, Ariba, and Accenture.
Voynick is currently board chair of AGS Health LLC, a revenue cycle management provider, and has held board positions for several other organizations, including Skydeck Acquisition Corp., CDK Global, Inc., r3, Advanced MD Health, Jefferson Health, Philadelphia University, and Thomas Jefferson University.
“Omnicell is at the forefront of delivering mission-critical medication management solutions, and I am honored to join the Board,” said Voynick. “As hospitals and health systems are relying on technology now more than ever to serve patients, I look forward to leveraging my background in software, healthcare, and operations and working alongside Randall and the rest of the Board as we continue to further our innovation agenda for the benefit of our customers and enhance stockholder value.”